The FDA cleared REBOHIL (BGM-1, BGM-2, BGM-3, BGM-4, BGM-5), a animal-source bone grafting material from Hyundai Bioland Co., Ltd. (Cheongju-Si, KR), under 510(k) K254210 on September 25, 2026.
- Source
- U.S. FDA 510(k) database
accessdata.fda.gov - Published
- September 25, 2026
- Type
- FDA
- Checked
- October 16, 2026
